EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Minimally invasive extracorporeal circulation versus conventional cardiopulmonary bypass in patients undergoing cardiac surgery (MiECS): Rationale and design of a multicentre randomised trial

Kyriakos Anastasiadis, Polychronis Antonitsis iD, Georgios Papazisis, Bettina Haidich, Andreas Liebold, Prakash Punjabi iD, Serdar Gunaydin iD, Aschraf El-Essawi iD, Vivek Rao, Cyril Serrick, Ignazio Condello iD, Giuseppe Nasso und 13 weitere

Perfusion · 2025

DOI: 10.1177/02676591241272009 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Perfusion, 2025. Verfasst von Kyriakos Anastasiadis und 24 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Department, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Cardiac Surgical Procedures, Cardiopulmonary Bypass, Coronary Artery Bypass, Extracorporeal Circulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The ultimate answer to the question whether minimal invasive extracorporeal circulation (MiECC) represents the optimal perfusion technique in contemporary clinical practice remains elusive. The present study is a real-world study that focuses on specific perfusion-related clinical outcomes after cardiac surgery that could potentially be favourably affected by MiECC and thereby influence the future clinical practice.

Methods

The MiECS study is an international, multi-centre, two-arm randomized controlled trial. Patients undergoing elective or urgent coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or combined procedure (CABG + AVR) using extracorporeal circulation will be randomized to MiECC or contemporary conventional cardiopulmonary bypass (cCPB). Use of optimized conventional circuits as controls is acceptable. The study design includes a range of features to prevent bias and is registered at clinicaltrials.gov (NCT05487612).

Results

The primary outcome is a composite of postoperative serious adverse events that could be related to perfusion technique occurring up to 30 days postoperatively. Secondary outcomes include use of blood products, ICU and hospital length of stay (30 days) as well as health-related quality of life (30 and 90 days).

Conclusions

The MiECS trial has been designed to overcome perceived limitation of previous trials of MiECC. Results of the proposed study could affect current perfusion practice towards advancement of patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac Surgical ProceduresCardiopulmonary BypassCoronary Artery BypassExtracorporeal CirculationMinimally Invasive Surgical ProceduresAgedFemaleHumansMaleMiddle AgedMulticenter Studies as TopicRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

cardiac surgerycardiopulmonary bypassextracorporeal circulationminimal invasive

Autor:innen und Institutionen

  • Cardiothoracic Department, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Special Unit for Biomedical Research and Education, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
  • Department of Hygiene, Social-Preventive Medicine and Medical Statistics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Department of Cardio-thoracic Surgery, University Hospital Ulm, Ulm, Germany.
  • Department of Cardiothoracic Surgery, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Department of Cardiovascular Surgery, Ankara City Hospital, University of Health Sciences, Ankara, Turkey.

ORCID-Profile: Polychronis Antonitsis, Prakash Punjabi, Serdar Gunaydin, Aschraf El-Essawi, Ignazio Condello, Gabor Erdoes

Zitieren

APA

Anastasiadis, K., Antonitsis, P., Papazisis, G., Haidich, B., Liebold, A., Punjabi, P., Gunaydin, S., El-Essawi, A., Rao, V., Serrick, C., Condello, I., Nasso, G., Bozok, S., Daylan, A., Argiriadou, H., Deliopoulos, A., Karapanagiotidis, G., Ashkanani, F., Moorjani, N., …, & Murkin, J. (2025). Minimally invasive extracorporeal circulation versus conventional cardiopulmonary bypass in patients undergoing cardiac surgery (MiECS): Rationale and design of a multicentre randomised trial. Perfusion. https://doi.org/10.1177/02676591241272009

Vancouver

Anastasiadis K, Antonitsis P, Papazisis G, Haidich B, Liebold A, Punjabi P, et al. Minimally invasive extracorporeal circulation versus conventional cardiopulmonary bypass in patients undergoing cardiac surgery (MiECS): Rationale and design of a multicentre randomised trial. Perfusion. 2025. doi:10.1177/02676591241272009

BibTeX
@article{Anastasiadis2025,
  author = {Anastasiadis, Kyriakos and Antonitsis, Polychronis and Papazisis, Georgios and Haidich, Bettina and Liebold, Andreas and Punjabi, Prakash and Gunaydin, Serdar and El-Essawi, Aschraf and Rao, Vivek and Serrick, Cyril and Condello, Ignazio and Nasso, Giuseppe and Bozok, Sahin and Daylan, Ahmet and Argiriadou, Helena and Deliopoulos, Apostolos and Karapanagiotidis, Georgios and Ashkanani, Fatma and Moorjani, Narain and Cale, Alex and Erdoes, Gabor and Bennett, Mark and Starinieri, Pascal and Carrel, Thierry and Murkin, John},
  title = {Minimally invasive extracorporeal circulation versus conventional cardiopulmonary bypass in patients undergoing cardiac surgery (MiECS): Rationale and design of a multicentre randomised trial},
  journal = {Perfusion},
  year = {2025},
  doi = {10.1177/02676591241272009}
}
Kostenlos starten →